Dr. Reddy's Lab gains on getting EIR for API manufacturing at Hyderabad

07 Oct 2019 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 2622.35, up by 5.90 points or 0.23% from its previous closing of Rs. 2616.45 on the BSE.

The scrip opened at Rs. 2655.00 and has touched a high and low of Rs. 2655.00 and Rs. 2591.60 respectively. So far 3593 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2965.20 on 02-May-2019 and a 52 week low of Rs. 2065.30 on 15-Feb-2019.

Last one week high and low of the scrip stood at Rs. 2739.10 and Rs. 2591.60 respectively. The current market cap of the company is Rs. 43121.47 crore.

The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 44.50% and 14.44% respectively.

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its API manufacturing plant 2 at Bollaram in the state of Hyderabad, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1275.15 0.10 (0.01%)
08-Dec-2025 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.05
Dr. Reddys Lab 1275.15
Cipla 1511.05
Zydus Lifesciences 932.30
Lupin 2089.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×